Details werden geladen...
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress | The ...
Media Release
Ähnliche Seiten
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/pliant-therapeutics-announces-upcoming-presentation-at-the-2026-american-society-of-clinical-oncology-annual-meeting/2349722Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/autolus-therapeutics-to-present-clinical-data-update-at-the-american-society-of-clinical-oncology-annual-meeting-2026/2349713Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine-pipeline/2349690Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting...
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/crescent-biopharma-announces-trial-in-progress-presentation-for-ascend-study-of-cr-001-a-pd-1-x-vegf-bispecific-antibody-at-upcoming-american-society-of-clinical-oncology-asco-2026-annual-meeting/2349723HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/hutchmed-highlights-clinical-data-to-be-presented-at-the-2026-asco-annual-meeting/2349755